Elevance Health earnings were $5.5B for the trailing 12 months ending Sep 30, 2025, with -11% growth year over year. The latest ELV earnings report on Sep 30, 2025 announced Q3 2025 earnings of $1.2B, down 31.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELV reported annual earnings of $6.0B, with -0.1% growth.
ELV past earnings growth
How has ELV's earnings growth performed historically?
What were Elevance Health's earnings last quarter?
On ELV's earnings call on Invalid Date, Elevance Health (NYSE: ELV) reported Q3 2025 earnings per share (EPS) of $5.32, up 21.46% year over year. Total ELV earnings for the quarter were $1.19 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $4.38.
As of the last Elevance Health earnings report, Elevance Health is currently profitable. Elevance Health's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $5.53 billion, a 13.79% decrease year over year.
What was ELV's earnings growth in the past year?
As of Elevance Health's earnings date in Invalid Date, Elevance Health's earnings has grown -11.04% year over year. This is 19.09 percentage points lower than the US Healthcare Plans industry earnings growth rate of 8.05%. ELV earnings in the past year totalled $5.53 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.